METABOLIC HEALTH—
It's Not Your Fault.
It May Be Your Insulin.
If you're South Asian and your weight looks normal paper, your cardiometabolic risk may still not be. Hidden visceral fat, low lean muscle, and insulin resistance can rnake fat loss harder and increase the risk of prediabetes, fatty liver, and heart disease.
Your BMI is lying to you
BMI measures weight, not where fat sits. Visceral fat , the kind wrapped around your liver and pancreas drives insulin resistance, raises inflammation, and lowers testosterone. Subcutaneous fat, the kind you can pinch, does far less damage.
South Asian men carry more visceral fat at every BMI than men of European descent. That's why standard cutoffs miss it.
2x
MORE VISCERAL FAT AT THE SAME BMI
4x
HIGHER TYPE 2 DIABETES RISK
10yrs
EARLIER ONSET OF HEART DISEASE
Does this sound like you?
- Belly weight that won't budge
- Normal weight, but soft through the middle
- Thin arms or low muscle tone
- Low energy or stalled progress
What insulin resistance can do
- Make belly fat harder to lose
- Slow metabolic efficiency
- Increase cravings and energy dips
- Raise cardiometabolic risk
How we help
- GLP therapy
- Personalized plans
- Peptide therapy
- Nutrition and metabolic support
- Body-composition-focused care
Where testosterone comes in
Fat tissue converts testosterone to estradiol. More visceral fat means more conversion and less available testosterone which makes it harder to build muscle and easier to store fat around the middle. The cycle tightens over years, quietly.
What this looks like
Fatigue
Poor sleep
Low libido
Belly fat
Brain fog
Muscle loss
Normal weight
How can I help people
Disclaimer: Results may vary. Images shown are for goal-setting purposes and include AI-generated representations.
Different thresholds, different risk
| Measure | Standard cutoff | South Asian cutoff |
|---|---|---|
| Overweight (BMI) | 25.0 | 23.0 |
| Obesity (BMI) | 30.0 | 27.5 |
| Waist circumference (men) | 40 in / 102 cm | 35 in / 90 cm |
A South Asian man at BMI 24 with a 36–inch waist is "normal weight" by standard criteria — and already past the threshold that applies to him.
What we actually measure
A standard physical won't find this. We test the markers that reveal visceral fat and insulin resistance before they become a diagnosis.
Hormonal
Total and free testosterone, SHBG, estradiol, LH and FSH, thyroid function
Metabolic
HbA1c, fasting glucose and insulin. HOMA-IR, liver enzymes, triglyceride-to-HDL ratio
Cardiovascular
Full lipid panel, APOB, lipoprotein(a), hs-CRP, blood pressure
Body composition
Waist circumference, waist—to-height ratio, body fat percentage and distribution
How we treat it
Visceral fat responds. It's often the first fat to move — but only when the plan targets the actual driver rather than the number on the scale.
Hormone optimization
Where labs confirm deficiency, restoring testosterone to mid-normal range improves lean mass and reduces visceral adiposity interrupting the cycle at its source.
GLP-I therapy
Semaglutide and tirzepatide reduce visceral fat and improve insulin sensitivity. Paired with adequate protein and resistance training to protect muscle.
Targeted peptides
Tesamorelin is FDA-approved specifically for the reduction of visceral adipose tissue, and is considered where clinically appropriate.
Metabolic foundation
Nutrition built around how you actually eat, resistance training, sleep, and ongoing lab monitoring not a generic plan.
Find out where you actually stand
A full metabolic and hormone panel, read against the thresholds that apply to you. Initial consultation is free.